CESR was renamed the Portfolio Pathway on 30 November 2023, following UK government legislation. The legal standard moved from "equivalence to a CCT" to "knowledge, skills and experience required to practise as a specialist in the UK". The Specialist Register outcome is identical. Most CESR-era evidence still counts; the framing and the assessment standard are what shifted.
The headline change
If you've been hearing both CESR (Certificate of Eligibility for Specialist Registration) and Portfolio Pathway in the same conversation and wondering whether they're the same thing, the short answer is yes. They refer to the same route to the General Medical Council's Specialist Register: the route that exists for doctors who haven't completed a GMC-approved UK training programme. CESR was the name from April 2010 until 30 November 2023. Portfolio Pathway has been the name since.
The same applies to the equivalent route for general practice. CEGPR (Certificate of Eligibility for GP Registration) was renamed Portfolio Pathway on the same date. One name now covers both specialist and GP routes.
What's harder to summarise in a sentence is what actually changed beneath the rebrand. The name is the surface. Under it sits a meaningful shift in the legal standard, a rewriting of every Specialty Specific Guidance document, and a transition policy that varies by Royal College. None of this changes the destination, but it does change how applicants gather and present evidence, and how Colleges assess it. Every article on this site that touches the route has been written or updated against the new framing. This article unpacks the change so the rest make sense in context.
Start with the Portfolio Pathway explained for an overview of the route end-to-end. This article is the companion piece for readers who specifically want to understand what changed in November 2023 and why.
The legislation behind the rebrand
The rename wasn't a GMC marketing decision. It followed legislation passed by the UK government: The Eligibility and Registration of General Practitioners and Specialist Medical Practitioners (Amendment) Order of Council 2022 (Statutory Instrument 2022/1326). That instrument substituted Article 8 of the Postgraduate Medical Education and Training Order of Council 2010, which is the primary legislation governing entry to the Specialist Register. The amendment came into force on 30 November 2023, which is why everything dated from that day.
The mechanical effect was a single wording change in Article 8. The old wording set the eligibility test as having qualifications and experience "equivalent to a CCT in the specialty in question". The new wording sets it as having "the knowledge, skills and experience required for practising as an eligible specialist or GP in the UK". On the page, that's a few words. In assessment terms, it's a reframe of the entire route.
The GMC then updated its application guidance and worked with each Royal College and Faculty to revise the Specialty Specific Guidance documents. Some of those updates landed at the rebrand date; others rolled out through 2024 as Colleges worked through their Capabilities in Practice frameworks. The GMC's summary of the change states the legislative driver was to give the GMC "more flexibility to accept a broader range of evidence" while preserving the standard.
From equivalence to knowledge, skills and experience
The single most useful way to understand the change is to compare the two standards side by side. The same applicant, with the same evidence, would have been assessed differently before and after 30 November 2023.
The short version: under CESR you proved that what you did matched what UK trainees do. Under the Portfolio Pathway you prove that you can do what a UK Consultant does. The destination is the same. The route to it is judged differently.
That distinction sounds subtle. In practice it changes how an assessor reads a portfolio. An applicant whose training was structured differently to a UK programme, but who now operates at full Consultant level in the NHS, no longer has to argue that their training was equivalent to a programme they didn't take. They argue that their current capability is at the level required, evidenced through what they actually do.
Under CESR you proved your training matched what UK trainees do. Under the Portfolio Pathway you prove you can do what a UK Consultant does.
The shift in framing, in one line.What changed for evidence
The categories of evidence are largely unchanged. The change is in how each piece is mapped, weighted, and described. Five practical shifts are worth noting.
1. Mapping is to high-level outcomes, not granular competencies
Older curricula listed dozens of fine-grained competency statements. CESR applicants matched evidence to each one. Newer curricula are organised around Capabilities in Practice: broader professional outcomes like "manages an unselected acute medical take" or "leads a multidisciplinary team meeting". Portfolio Pathway evidence is mapped to the relevant CiPs, with each piece cross-referenced rather than counted. Read the full Capabilities in Practice guide for how this works in detail.
2. Quality is weighted over quantity
Some Royal Colleges have explicitly told applicants they will not set indicative numbers under the Portfolio Pathway, because volume of evidence has been a misleading signal in the past. The Royal College of Paediatrics and Child Health (RCPCH) made this point directly: a strong, well-mapped piece of evidence beats five generic ones. Other Colleges, particularly procedural specialties, still publish indicative procedure numbers, but the framing is "demonstrate you can do this", not "tick this off".
3. The five-year rule is more flexible in some specialties
Most specialties retain the principle that the bulk of evidence should be from the last five years. The Royal College of Pathologists explicitly accepts evidence from the last 10 years for the pathology specialties, with older evidence allowed in support. Other Colleges sit closer to the five-year norm. The exact recency expectation is in your specialty's SSG. We cover this in our recent-evidence article.
4. Structured reports carry more weight
Because the assessment is now of capability rather than training equivalence, the views of senior colleagues who have observed your work matter more, not less. The structured reports from referees are some of the heaviest-weighted evidence in a Portfolio Pathway portfolio. Choosing and briefing referees well is a separate skill, and one of the more common reasons applications stall.
5. The narrative commentary matters more
Most colleges now ask applicants to submit a structured commentary alongside the evidence, mapping pieces to CiPs and explaining why each piece demonstrates the relevant capability. The Royal College of Pathologists calls this the "Portfolio Pathway Applicant Template". Other Colleges have equivalents. Under CESR the commentary was lighter; under the Portfolio Pathway it's a meaningful piece of work in its own right.
What stayed the same
Plenty did. If you've been gathering evidence for a year or two under the CESR name, almost everything you've done remains directly useful. The list below is the bedrock that didn't move.
- The destination: entry on the GMC Specialist Register, the legal prerequisite for substantive NHS Consultant posts.
- The application route: through GMC Online, evaluated by the relevant Royal College or Faculty.
- The fee structure: same GMC application fee model, indexed annually.
- The 24-month application window: starts when you open your application, not when you submit.
- The evidence categories: clinical case logs, WPBAs, audit, MSF, structured reports, reflection, teaching, leadership, CPD.
- The eligibility criteria: not having completed a GMC-approved UK training programme; for non-CCT specialties, an overseas specialist qualification or 6+ months specialist training.
- The Royal College / Faculty assessor model: applications are still evaluated by specialist assessors within Colleges.
- The typical timeline: still two to four years for most candidates from starting evidence to Register entry.
If a piece of advice was true under CESR and concerns evidence collection, application mechanics, or eligibility, it's almost certainly still true. Where the rules genuinely shifted is in evidence framing and assessment, which is what this article focuses on.
You don't need to redo any evidence. Re-title the commentary against the current Capabilities in Practice and the current Specialty Specific Guidance, and submit. Most CESR-era portfolios remap cleanly.
How the Royal Colleges adapted
The legislation set the standard. Each Royal College and Faculty then translated that into specialty-specific guidance. The result is meaningful variation across specialties in how the change has been implemented. The cards below summarise the position of the larger Colleges: the Royal College of Physicians (RCP) and its training board (JRCPTB), the Royal College of Pathologists (RCPath), the Royal College of Paediatrics and Child Health (RCPCH), the Royal College of Radiologists (RCR), the Faculty of Intensive Care Medicine (FICM), and the Royal College of Obstetricians and Gynaecologists (RCOG).
Operates a dual curricula transition policy: applicants can apply against the previous curriculum for two to three years after a new one publishes, depending on the scale of change. New curricula use Capabilities in Practice. The Federation has detailed transition deadlines per specialty. Now also offers dual certification in Geriatric Medicine and General Internal Medicine for eligible applicants.
Updated the Specialty Specific Guidance for each pathology specialty. Accepts evidence from the last 10 years with older material in support where it adds breadth. FRCPath remains the strongest demonstration of knowledge. Applicants submit a Portfolio Pathway Applicant Template mapping evidence to CiPs.
Mapped existing CESR evidence types directly across to the new framework. Has explicitly stated it will not set indicative numbers for evidence under the Portfolio Pathway, on the grounds that volume can mislead applicants. Quality and mapping carry the weight.
Reported in late 2024 that Portfolio Pathway-route applicants now account for around one-third of all new Clinical Radiology Consultants, with applications up 82% in 2023. CiPs are central to the assessment, and indicative reporting numbers and procedure logs remain part of the SSG.
Assesses Portfolio Pathway applications for ICM as a primary specialty. The 2021 ICM curriculum is structured around CiPs, so the move from equivalence to KSE was a smaller shift than in some other specialties. Dual specialty applications (ICM with Anaesthetics, Acute Medicine, etc.) follow specific guidance.
Reframed assessment around KSE standards and ran applicant webinars in 2023 and early 2024 to walk through the transition. Stresses that the Portfolio Pathway allows applicants to meet the curriculum's key skills "in a more personalised way", with structured reports carrying significant weight.
The variation matters. Two applicants in different specialties working from the same generic GMC guidance will hit different evidence expectations. Your specialty's SSG is the document that tells you what your College wants. Read it before you map a single piece of evidence.
The transitional arrangements
The legislation was prospective. Applications submitted before 30 November 2023 continued through their existing process, with assessment still moving to the new standard for any decisions issued from that date forward. The GMC and Colleges advised applicants in flight at the time not to delay submission and not to rush it; the transition was explicitly designed not to disadvantage applicants either way.
The visual below traces the timeline from the legislative announcement through the rebrand and into the transition period that's still running in some specialties.
The most interesting transition arrangement sits with the JRCPTB (Federation of physician colleges). Where a specialty's curriculum changed alongside the rebrand, applicants are allowed to apply against the previous curriculum for two to three years after the new one publishes, depending on how significant the curriculum change was. The previous curriculum is then retired on a published deadline. This matters because some applicants who started gathering evidence years ago can still legitimately apply against the curriculum they began under.
Other Colleges have either folded the transition into a single rewrite of their SSG (RCPath, RCPCH) or treated it as a framing change with no curriculum impact (RCR, FICM, where CiPs were already in place). The variation is real, and it's why generic guidance only takes you so far.
What this means if you're applying now
Five concrete things to do, regardless of where you are in the route.
Read the current SSG, not the version saved to your laptop
SSGs were updated for the rebrand. If your saved copy is from 2022 or 2023, it's out of date. Always work from the version live on the GMC website. The SSG is the single most important document for your application.
Map evidence to Capabilities in Practice, not granular competencies
If you've been organising your portfolio against a granular competency list, restructure to CiPs. The pieces of evidence are the same; the index changes. Most Colleges publish a CiP-by-CiP template you can use as a backbone.
Strengthen the narrative commentary
Each piece of evidence needs a short reflection and a clear explanation of why it demonstrates the relevant capability. Under the Portfolio Pathway, the commentary is doing more work than it did under CESR. Read assessor briefings on what good commentary looks like; most Colleges publish examples.
Brief your referees on the new framing
If you asked for structured reports a year ago, the references may have been written against the old equivalence-to-CCT wording. Either ask your referees to refresh them against the KSE standard, or write a covering note explaining how the existing report demonstrates current capability. Don't submit reports that read against an old standard without that context.
Check whether your specialty has a transition policy you can use
If you're in a physician specialty and started under an older curriculum, the JRCPTB transition policy may let you apply against that curriculum for a defined window. Check your specialty's published transition deadline before deciding which curriculum to apply under.
Common misconceptions worth clearing up
The rebrand has produced some confused commentary, both from candidates and from competitor recruitment blogs. Five worth correcting.
"The Portfolio Pathway is easier than CESR." No. The clinical bar is the same, set by the same Colleges, assessed by the same panels. What's changed is the flexibility around how evidence is collected and presented. A direct-from-overseas application, in particular, is not meaningfully easier. The framing change helps applicants whose path didn't mirror UK training, but it doesn't lower the standard.
"I need to start over because the rules changed." No. Your CESR-era evidence still counts. The exception is references that were written tightly against the CCT-equivalence wording; those benefit from a covering note or a refresh. Everything else remaps.
"Only IMGs use the Portfolio Pathway." No. The largest single category of successful applicants in our experience is non-substantive Consultants already working in the UK on fixed-term, locum, or specialist grade contracts. Senior SAS doctors are the second largest. Internationally-trained doctors applying directly from overseas are a meaningful but smaller cohort, and direct-from-overseas applications remain particularly challenging.
"It's faster now." No. The structural processing time hasn't changed. The GMC still takes six to twelve months to process a complete application, and Colleges still need 36 working days to evaluate it. The bottleneck for most candidates remains preparing the portfolio, not the processing time. We cover the realistic timeline in our timeline article.
"CESR is dead, never use the term." Pragmatically, no. NHS job adverts, peer-support groups, and many Trust documents still use CESR. The GMC and Royal Colleges have moved to Portfolio Pathway in their primary materials, but "CESR" persists in clinical conversation and will for a while. If you see "CESR-supportive Trust" in a job advert in 2026, it means the same thing it did in 2022.
The rebrand softened the framing for IMGs by removing the strict equivalence test. It did not make direct-from-overseas applications routine. The GMC and Colleges still expect evidence that mirrors NHS practice closely, and that's genuinely difficult to compile from a healthcare system structured differently to the UK. For most internationally-trained doctors, the more realistic route is to take a UK post first, then build the portfolio from inside the system. We're honest about this where competitor blogs are not.
Where to start with your specialty
The single most useful first step, if you haven't already, is reading your specialty's current Specialty Specific Guidance on the GMC website. After that, our specialism overview articles cover the curriculum, CiPs, evidence patterns, and Royal College specifics for each of 17 specialisms.
If you'd like the broader picture of the route end to end, the foundational guide is the Portfolio Pathway explained. For eligibility, see the eligibility self-assessment. For the four GMC domains the framework rests on, see the four domains article.